PMID- 30022843 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220331 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 11 DP - 2018 TI - Depression in people with type 2 diabetes: current perspectives. PG - 333-343 LID - 10.2147/DMSO.S106797 [doi] AB - Type 2 diabetes mellitus (T2DM) is associated with depressive symptoms, and comorbid depression in those with T2DM has been associated with adverse clinical profiles. Recognizing and addressing psychological symptoms remain significant clinical challenges in T2DM. Possible mediators of the reciprocal relationship between T2DM and depression may include physical activity levels, effectiveness of self-management, distress associated with a new T2DM diagnosis, and frailty associated with advanced diabetes duration. The latter considerations contribute to a "J-shaped" trajectory from the time of diagnosis. There remain significant challenges to screening for clinical risks associated with psychological symptoms in T2DM; poorer outcomes may be associated with major depressive episodes, isolated (eg, anhedonic), or subsyndromal depressive symptoms, depressive-like symptoms more specific to T2DM (eg, diabetes-related distress), apathy or fatigue. In this review, we discuss current perspectives on depression in the context of T2DM with implications for screening and management of these highly comorbid conditions. FAU - Darwish, Lina AU - Darwish L AD - Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Cardiac Rehabilitation Program, University Health Network Toronto Rehabilitation Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Canadian Partnership for Stroke Recovery, Toronto, ON, Canada, w.swardfager@utoronto.ca. FAU - Beroncal, Erika AU - Beroncal E AD - Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Cardiac Rehabilitation Program, University Health Network Toronto Rehabilitation Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. FAU - Sison, Ma Veronica AU - Sison MV AD - Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Cardiac Rehabilitation Program, University Health Network Toronto Rehabilitation Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. FAU - Swardfager, Walter AU - Swardfager W AD - Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Cardiac Rehabilitation Program, University Health Network Toronto Rehabilitation Institute, Toronto, ON, Canada, w.swardfager@utoronto.ca. AD - Canadian Partnership for Stroke Recovery, Toronto, ON, Canada, w.swardfager@utoronto.ca. LA - eng PT - Journal Article PT - Review DEP - 20180710 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC6044353 OTO - NOTNLM OT - complications OT - depression OT - mood OT - type 2 diabetes COIS- Disclosure The authors report no conflicts of interest in this work. EDAT- 2018/07/20 06:00 MHDA- 2018/07/20 06:01 PMCR- 2018/07/10 CRDT- 2018/07/20 06:00 PHST- 2018/07/20 06:00 [entrez] PHST- 2018/07/20 06:00 [pubmed] PHST- 2018/07/20 06:01 [medline] PHST- 2018/07/10 00:00 [pmc-release] AID - dmso-11-333 [pii] AID - 10.2147/DMSO.S106797 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2018 Jul 10;11:333-343. doi: 10.2147/DMSO.S106797. eCollection 2018.